EGFR and breast carcinoma: Moreover, a recent report has shown that ZD6474 can evaluate the feasibility and efficacy of combined VEGFR2 and EGFR in breast cancer cells, which may be an alternative approach to the ongoing conventional cancer radiotherapy [32].